We target the cells
that drive fibrosis
Activated myofibroblasts play a pivotal role in fibrosis. To reach these cells, we designed Fibrobodies®. These proprietary and first-in-class proteins bind selectively to activated myofibroblasts in fibrotic tissue.
Fibrobodies® can be equipped with virtually any ‘payload’, unlocking various possibilities to diagnose and treat fibrosis.
Research points to long-term growth in a multitude of fibrotic illnesses.
Our team of dedicated scientists have broad experience in targeted drug delivery. Within the Amsterdam UMC Imaging Center, we have access to state-of-the-art facilities including radioactive tracer production facilities, chemical and biochemical laboratories, preclinical facilities, and preclinical- and clinical Imaging equipment (PET/CT, PET/MRI).
LinXis B.V.
Noordhollandstraat 71
1081 AS Amsterdam
The Netherlands